Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort-Reference-Cited by-同舟云学术

Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort

Published:2016-06-11 Issue:1 Volume:17 Page:
ISSN:1471-2369
Container-title:BMC Nephrology
language:en
Short-container-title:BMC Nephrol

Author:

Busch Martin, ,Nadal Jennifer,Schmid Matthias,Paul Katharina,Titze Stephanie,Hübner Silvia,Köttgen Anna,Schultheiss Ulla T.,Baid-Agrawal Seema,Lorenzen Johan,Schlieper Georg,Sommerer Claudia,Krane Vera,Hilge Robert,Kielstein Jan T.,Kronenberg Florian,Wanner Christoph,Eckardt Kai-Uwe,Wolf Gunter

Funder

Bundesministerium für Forschung und Technologie

KfH Foundation for Preventive Medicine

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1186/s12882-016-0273-z

Reference42 articles.

1. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260–72.

2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.